Mr. Chair, the health and well-being of our Canadian Armed Forces members are paramount, and malaria is a potentially life-threatening infectious disease to which our troops could be exposed in the performance of their duties. A military member's decision on malaria prevention is made in close consultation with his or her health care provider. Mefloquine currently remains as one of the medications approved by Health Canada and recommended by the Public Health Agency of Canada that is available to military personnel to prevent malaria. The use of mefloquine is now the exception and not the trend of recent years. The use of mefloquine by the Canadian Armed Forces is in the final stages of being reviewed, and the decision on this matter is expected in the near future.
In the House of Commons on May 29th, 2017. See this statement in context.